Market Cap | 24.26M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
Income | -15.55M | Forward P/E | - | EPS next Y | - | 50D Avg Chg | 59.00% |
Sales | - | PEG | - | EPS past 5Y | - | 200D Avg Chg | 35.00% |
Dividend | N/A | Price/Book | 2.61 | EPS next 5Y | - | 52W High Chg | -62.00% |
Recommedations | - | Quick Ratio | 1.85 | Shares Outstanding | 2.72M | 52W Low Chg | 153.00% |
Insider Own | - | ROA | -67.80% | Shares Float | 274.57M | Beta | - |
Inst Own | 2.06% | ROE | -225.89% | Shares Shorted/Prior | 4.78K/2.50K | Price | 1.41 |
Gross Margin | - | Profit Margin | - | Avg. Volume | 431,453 | Target Price | - |
Oper. Margin | - | Earnings Date | - | Volume | 743,596 | Change | -6.00% |
Steakholder Foods Ltd., a deep-tech food company, engages in the development of cultivated meat technologies to manufacture cultivated meat without animal slaughter in Israel. The company develops a three-dimensional bioprinter to deposit layers of stem cells and differentiated stem cells, scaffolding, and cell nutrients in a three-dimensional form of structured cultured meat. It intends to license its production technology; provides associated products, such as cell lines, printheads, bioreactors, and incubators; and offers technology implementation, training, and engineering support services directly and through contractors to food processing, food retail, and cultivated meat companies. Steakholder Foods Ltd. is headquartered in Rehovot, Israel.